KRAS and pancreatic neoplasm: Studies have shown that LFNG deficiency accelerates KRAS-induced pancreatic cancer development in mice [20], while LFNG expression inhibition suppresses pancreatic cancer cell proliferation and migration by inhibiting NOTCH1 activation [21].